ID   ECN90
AC   CVCL_VJ07
DR   Wikidata; Q93537272
RX   Patent=US9493743;
RX   Patent=WO2017046335A1;
CC   Group: Patented cell line.
CC   HLA typing: A*02:01,03; B*40,49; C*03,07 (Patent=WO2017046335A1).
CC   Transfected with: HGNC; 11730; TERT.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
RX   Patent=US9493743;
RA   Czernichow P., Ravassard P., Scharfmann R.;
RT   "Production of a human beta cell line from an early post natal pancreas.";
RL   Patent number US9493743, 15-Nov-2016.
//
RX   Patent=WO2017046335A1;
RA   Mallone R., Afonso G., Lalanne A.I., Culina S.;
RT   "T cell receptors (TCR) and uses thereof for the diagnosis and treatment of
RT   diabetes.";
RL   Patent number WO2017046335A1, 23-Mar-2017.
//